Visen Pharmaceuticals (2561)
Market Open
5 Oct, 08:00 AM
HKEX HKEX Primary 18. 99
HKD +0.49
+2.6486%
3.5B Market Cap
- P/E Ratio
- Div Yield
2,100 Volume
- Eps
18.5 HKD
Previous Close Want to track 2561 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Visen Pharmaceuticals (2561) Statistics
Valuation metrics
Market Cap 3.5B
Enterprise value 1.39B
Trailing P/E (ttm) -7.13
Forward P/E -9.26
PEG ratio -19.66
Price/Sales (ttm) 84.06
Price/Book (mrq) 2.56
Enterprise Value/Revenue 67.93
Enterprise Value/EBITDA -5.95
Overview
Shares outstanding 109.04M
Float 25.41M
Shares short -
% Held by insiders 0.47%
% Held by institutions 0.47%
Average volume (10 days) 3.75K
Average volume (90 days) 15.46K
Price summary
52-Week low 18.5
52-Week high 45
Beta -
50-Day moving average 19.2
200-Day moving average 21.46
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2024
Profitability
Profit margin -11.74%
Operating margin -11.57%
Operational effectiveness
Return on assets -0.27%
Return on equity -0.33%
Income Statement
Revenue (ttm) 156.44K
Revenue per share (ttm) 0.19
Quarterly revenue growth (yoy) -
Gross profit (ttm) -11.5K
EBITDA -275.05M
Net income to common (ttm) -291.52M
Diluted EPS (ttm) -2.19
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 727.75M
Total cash per share (mrq) 4.62
Total debt (mrq) 203.59M
Total Debt/Equity (mrq) 0.26
Current ratio (mrq) 4%
Book value per share (mrq) 6.13
Cash Flow
Cash flow statement -189.43M
Levered free cash flow (LFCF) -253.42M
2026 © Marketlog. All Rights Reserved.
